# Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma

> **NCT07751380** · PHASE1 · RECRUITING · sponsor: **University College, London** · enrollment: 12 (estimated)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Biological/Vaccine: hBRCA84D CAR T cells

## Key facts

- **NCT ID:** NCT07751380
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-23
- **Primary completion:** 2028-07
- **Final completion:** 2042-07
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751380, "Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07751380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*